Literature DB >> 7056275

Kinetics of a high dose of piretanide in renal failure.

J L Brazier, N Pozet, G Faucon, J Traeger, A Hadj-Haissa.   

Abstract

The kinetics of piretanide was studied in patients with renal failure. After oral administration of a high dose of piretanide (96 mg), the pharmacokinetic parameters were: elimination rate constant 0.346 +/- 0.072 h-1, half life 2.00 +/- 0.35 h, and total plasma clearance 119.55 +/- 35.90 ml x min-1. Compared to the values obtained in adults with normal renal function, these results show a decrease in total plasma clearance, but conservation of the metabolic clearance which amounts to 45% of the total clearance in the healthy adult.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056275     DOI: 10.1007/bf00637618

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Elimination of furosemide in healthy subjects and in those with renal failure.

Authors:  B Beermann; E Dalén; B Lindström
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

2.  Pharmacokinetics and pharmacodynamics of Lasix.

Authors:  W Rupp
Journal:  Scott Med J       Date:  1974       Impact factor: 0.729

3.  Pharmacokinetics of furosemide in advanced renal failure.

Authors:  C M Huang; A J Atkinson; M Levin; N W Levin; A Quintanilla
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

4.  Pharmacokinetics of furosemide in normal subjects and functionally anephric patients.

Authors:  R E Cutler; A W Forrey; T G Christopher; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

5.  Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia.

Authors:  A Rane; J P Villeneuve; W J Stone; A S Nies; G R Wilkinson; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

6.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

7.  Furosemide kinetics in renal failure.

Authors:  W J Tilstone; A Fine
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

8.  Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.

Authors:  C Marone; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

9.  Activity of a new high efficiency diuretic in man: piretanide (HOE 118).

Authors:  N Pozet; A Hadj-Aissa; M Pellet; J Traeger
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

  9 in total
  7 in total

Review 1.  Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.

Authors:  P Reetze-Bonorden; J Böhler; E Keller
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of some newer diuretics.

Authors:  B Beermann; M Grind
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 4.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

5.  The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.

Authors:  K J Berg; R A Walstad; K Bergh
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

6.  Pharmacokinetics of high doses of piretanide in moderate to severe renal failure.

Authors:  C Marone; F C Reubi; M Perisic; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Pharmacokinetics of the loop diuretic piretanide in renal failure.

Authors:  U Walter; A Röckel; W Lahn; A Heidland; W Heptner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.